EUVIMEDEUVIMED entdecken
Crossref

Myeloid Cell Protein Tyrosine Phosphatase 1B Drives Retinal Neurodegeneration in Diabetic Mice

Ayaz Ali, Morgan Boyne, Abrar Othman, Sarah Kamli-Salino, Lucia Kuffova, John V Forrester iD, Mirela Delibegovic iD

Diabetes · 01.07.2026 · 75 (7) · 1272-1284

DOI: 10.2337/db25-0904 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, online erschienen am 21.05.2026. Verfasst von Ayaz Ali und 6 weiteren Autor:innen. Beteiligte Einrichtung: Aberdeen Cardiovascular and Diabetes Centre, Institute of Medical Sciences, University of Aberdeen, Aberdeen, U.K. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 1, Diabetic Retinopathy, Diabetes Mellitus, Experimental, Retinal Degeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) is the leading cause of vision loss in the working-age population, with public health economic implications worldwide. Systemic inflammation and leukocyte activation are early events in diabetes, whereas microglial activation, neuroinflammation, and retinal neurodegeneration are early events in DR. Protein tyrosine phosphatase 1B (PTP1B) plays a complex role in monocyte and macrophage activation, which may affect DR. We investigated the role of myeloid cell–specific PTP1B using LysMcre-PTP1B fl/fl (LysM-PTP1B) transgenic mice, as well as pharmacological inhibition with a PTP1B inhibitor, MSI-1436, in the early stages of DR. Mice were rendered diabetic for 6 weeks using anomer-equilibrated streptozotocin (STZ). Retinal changes were evaluated by histology and immunohistochemistry, and systemic leukocyte activation by flow cytometry. Mitochondrial function in high-glucose-concentration-challenged, cultured bone marrow–derived macrophages (BMDMs) from LysM-PTP1B– and MSI-I436–treated mice was determined in vitro. Both myeloid cell–specific depletion and pharmacological inhibition of PTP1B prevented STZ-induced retinal neurodegeneration, development of acellular retinal capillaries, as well as microglial and systemic leukocyte activation without altering the development of diabetes. In vitro, inhibition of PTP1B prevented high-glucose-level-induced mitochondrial dysfunction in BMDMs. We conclude that inhibition of PTP1B prevents DR by decreasing myeloid cell–driven inflammation, and PTP1B represents a therapeutic target for prevention DR. Article Highlights Myeloid cell PTP1B is required to induce retinal neurodegeneration in diabetes. Both local (microglia) and systemic (bone marrow–derived) myeloid cells are implicated. Inhibition of myeloid cell PTP1B prevents development of acellular retinal capillaries in diabetic mice. PTP1B mediates superoxide production, decreases mitochondrial membrane potential, and, in female mice, increases macrophage cell death in chronic conditions associated with abnormally high glucose levels. Protective effects of PTP1B deletion on diabetic retinopathy were also observed in mice treated with the small molecular PTP1B inhibitor MSI-1436; both retinal neurodegeneration and local glial cell activation were decreased.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Tyrosine Phosphatase, Non-Receptor Type 1Diabetic RetinopathyDiabetes Mellitus, ExperimentalRetinal DegenerationMyeloid CellsRetinaAnimalsMiceMice, TransgenicMaleMacrophagesMice, Inbred C57BL

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 1Ptpn1 protein, mouse

Autor:innen und Institutionen

  • Aberdeen Cardiovascular and Diabetes Centre, Institute of Medical Sciences, University of Aberdeen, Aberdeen, U.K.
  • Aberdeen Ophthalmology Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen, U.K.
  • Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia.
  • INSiGHT Comprehensive Eye Care, Hamilton, Bermuda.

ORCID-Profile: John V Forrester, Mirela Delibegovic

Förderung

  • British Heart Foundation

Zitieren

APA

Ali, A., Boyne, M., Othman, A., Kamli-Salino, S., Kuffova, L., Forrester, J. V., & Delibegovic, M. (2026). Myeloid Cell Protein Tyrosine Phosphatase 1B Drives Retinal Neurodegeneration in Diabetic Mice. Diabetes, 75(7), 1272-1284. https://doi.org/10.2337/db25-0904

Vancouver

Ali A, Boyne M, Othman A, Kamli-Salino S, Kuffova L, Forrester JV, et al. Myeloid Cell Protein Tyrosine Phosphatase 1B Drives Retinal Neurodegeneration in Diabetic Mice. Diabetes. 2026;75(7):1272-1284. doi:10.2337/db25-0904

BibTeX
@article{Ali2026,
  author = {Ali, Ayaz and Boyne, Morgan and Othman, Abrar and Kamli-Salino, Sarah and Kuffova, Lucia and Forrester, John V and Delibegovic, Mirela},
  title = {Myeloid Cell Protein Tyrosine Phosphatase 1B Drives Retinal Neurodegeneration in Diabetic Mice},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {7},
  pages = {1272--1284},
  doi = {10.2337/db25-0904}
}
Kostenlos starten →